miscsubjectsAI governance
Evidence review

Retatrutide for Muscle Loss: Body Composition Evidence

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `retatrutide-muscle-loss`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/retatrutide-muscle-loss

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/retatrutide-muscle-loss/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/retatrutide-muscle-loss/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/retatrutide-muscle-loss/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/retatrutide-muscle-loss/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why Retatrutide might help you

  1. What keeps failing: Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.
  2. What Retatrutide is studied to do: Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.
  3. Therefore for you: If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Retatrutide → metabolic load / body weight

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 2
  • Reddit posts catalogued: 1
  • X posts catalogued: 1
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Quantified confidence (this ledger): 0.38 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2 trial (source s1)

Phase 2 substudy results on fat and lean mass changes with retatrutide vs comparators in T2D patients.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial (source s2)

Primary weight loss efficacy data from the phase 2 obesity trial.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide, in MC4R knockout obese mice (source s3)

Preclinical animal data on body composition effects including lean mass.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

What people say on Reddit

Terrible muscle loss - any suggestions? — Reddit, r/Retatrutide (source s4)

User discussion on muscle loss experiences and mitigation strategies.

What people say on X

X post on retatrutide lean mass data — X (source s5)

Example of X discussion citing trial lean mass percentages.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Muscle loss / sarcopenia · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 5 sources · swipe →chain 23f55be48f4b · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
anecdotal
X discussions note that lean mass loss with retatrutide is approximately 35-38% of total weight lost, comparable to other GLP-1 drugs.
sources: s5
humanlow confidence
In a 2025 phase 2 substudy, retatrutide at 8-12 mg doses reduced total fat mass by up to 26.1% at week 36 in adults with type 2 diabetes, with lean mass loss proportion similar to other obesity treatments.
sources: s1
humanlow confidence
The main 2023 phase 2 obesity trial reported up to 24.2% mean weight reduction at 48 weeks with 12 mg retatrutide but lacked detailed lean/fat mass breakdown.
sources: s2
preclinicallow confidence
Animal models have shown reductions in both fat and lean mass, including soleus muscle weight, with GLP-1 analogs including retatrutide.
sources: s3
anecdotallow confidence
Reddit users commonly report muscle or strength loss on retatrutide mitigated by high protein intake and resistance training.
sources: s4
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 00:57
Retatrutide for Muscle Loss: Body Composition Evidence · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Retatrutide for Muscle Loss
Slug: retatrutide-muscle-loss
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"retatrutide","name":"Retatrutide"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative
it output
{
  "slug": "retatrutide-muscle-loss",
  "title": "Retatrutide for Muscle Loss: Body Composition Evidence",
  "body": "## What's breaking down\nMuscle loss, or sarcopenia in some contexts, occurs when breakdown outpaces repair in skeletal muscle tissue. Excess body weight can accelerate mechanical stress on muscles and joints, while rapid weight loss from calorie restriction or medications often includes lean mass reduction alongside fat loss. In the case of GLP-1 receptor agonists, weight reduction frequently accounts for 15-40% of total loss from lean tissue in human trials. Retatrutide, as a triple agonist, drives substantial overall weight loss, raising questions about its specific impact on muscle relative to fat.\n\n## Why Retatrutide might help you\n1. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\n2. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\n3. **Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\n\nIf your muscle loss ties to carrying extra body weight, reduced load from weight loss may ease ongoing stress on muscle maintenance pathways. Retatrutide's glucagon component may increase e
596cf017a92e32a0
Machine verification: /api/articles/retatrutide-muscle-loss/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (anecdotal tier): "X discussions note that lean mass loss with retatrutide is approximately 35-38% of total weight lost, comparable to other GLP-1 drugs."?
ask retatrutide-muscle-loss claim c5 · paste includes §SELF
What does the ledger say about this (human tier): "In a 2025 phase 2 substudy, retatrutide at 8-12 mg doses reduced total fat mass by up to 26.1% at week 36 in adults with type 2 diabetes, wi…"?
ask retatrutide-muscle-loss claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "The main 2023 phase 2 obesity trial reported up to 24.2% mean weight reduction at 48 weeks with 12 mg retatrutide but lacked detailed lean/f…"?
ask retatrutide-muscle-loss claim c2 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Animal models have shown reductions in both fat and lean mass, including soleus muscle weight, with GLP-1 analogs including retatrutide."?
ask retatrutide-muscle-loss claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users commonly report muscle or strength loss on retatrutide mitigated by high protein intake and resistance training."?
ask retatrutide-muscle-loss claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User discussion on muscle loss experiences and mitigation strategies."
ask retatrutide-muscle-loss source s4 · paste includes §SELF
Summarize this x report and how it should weigh: "Example of X discussion citing trial lean mass percentages."
ask retatrutide-muscle-loss source s5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about Retatrutide for Muscle Loss: Body Composition Evidence — and what would you need me to tell you first?
ask retatrutide-muscle-loss condition gaps · paste includes §SELF
retatrutide-muscle-loss · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 38883 tokens · $0 · 2 models
chain head c4022fcee8323711
write grok/grok-4.3 · 2026-06-30 00:57 · 38883 tok · 4aa477407d12
voxel_divide owner · 2026-07-17 02:41 · 0 tok · c4022fcee832
verify chain →
Live ledger · 6 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 21:52
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 21:32
JCI_CLASSIFY jci · HTTP 200 · 2026-07-19 06:56
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 06:56
PROTOCOL_RUN dispatch · 2026-06-30 00:57 · t_shxhu9p8
PROTOCOL_RUN dispatch · 2026-06-30 00:57 · t_shxhu9p8
view full ledger & cards →
REST + ledger
read GET /api/articles/retatrutide-muscle-loss · GET /api/articles/retatrutide-muscle-loss?format=post (the editable body)
create/replace POST /api/articles/retatrutide-muscle-loss · PUT /api/articles/retatrutide-muscle-loss (replace, keeps revision) · PATCH /api/articles/retatrutide-muscle-loss (merge)
delete DELETE /api/articles/retatrutide-muscle-loss
writes need header x-terminal-key
LLM bundle GET /api/articles/retatrutide-muscle-loss/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim retatrutide-muscle-loss|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…